The Movement Imagery Ability in Patients With Familial Mediterranean Fever

NCT ID: NCT04729218

Last Updated: 2022-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2021-02-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Motor imagery is the mental representation of movement without any doing body movement. A main function of imagery is to aid the self-regulation of thoughts, feelings, and behaviours. Studies have shown to be more effective for individuals displaying a higher level of imagery ability when using imagery to improve motor and motivational outcomes, including self-efficacy. The aim of this study is to measure the movement imagery ability in patients with Familial Mediterranean Fever and compare it with healthy individuals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Familial Mediterranean Fever (FMF) is an autosomal recessive disease characterized by recurrent and self-limited attacks of fever associated with abdominal, chest, and joint pain. Previous studies have shown that individuals with FMF are more limited in terms of physical function than the normal population, and depression and anxiety are more common in these individuals. Being a lifetime disease, quality of life, and mental health can be affected due to serious complications such as attack frequency, disease resistance, and sometimes amyloidosis. Mental imagery is the ability to imaging the movement without doing the physical execution of the movement. During the last years, mental imagery is used in clinical practice as a tool for the treatment of chronic pain. Pain differs in patients with rheumatic diseases. Stress is one of the predictors of pain in patients with FMF. Even if the frequency is variable when attacks happen they may affect patients physically and their mental health and the ability to cope. A main function of imagery is to aid the self-regulation of thoughts, feelings, and behaviors. To use imagery for motor and motivational outcomes firstly the imagery ability levels should be measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Familial Mediterranean Fever

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Familial Mediterranean Fever group

30 participants

movement imagery ability

Intervention Type BEHAVIORAL

Determining the movement imagery ability: internal visual, external visual and kinesthetic imagery

Healthy group

30 participants

movement imagery ability

Intervention Type BEHAVIORAL

Determining the movement imagery ability: internal visual, external visual and kinesthetic imagery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

movement imagery ability

Determining the movement imagery ability: internal visual, external visual and kinesthetic imagery

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* having had at least one attack last year
* co-operated individuals

Exclusion Criteria

* patients with a neurological disorder,
* diagnosed with cancer,
* cognitive impairment,
* having a primary pathology of the musculoskeletal system,
* having previous imagery practice,
* having an additional rheumatic disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University - Cerrahpasa

OTHER

Sponsor Role collaborator

Medipol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Albina Alikaj

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Albina Alikaj, MSc

Role: PRINCIPAL_INVESTIGATOR

Medipol University

Ahsen Büyükaslan, MSc

Role: STUDY_CHAIR

Medipol University

Serdal Uğurlu, Prof

Role: STUDY_DIRECTOR

Istanbul University - Cerrahpasa

Burcu Dilek, PhD

Role: STUDY_DIRECTOR

Acibadem University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul University, Cerrahpaşa Medical Faculty, Department of Rheumatology

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.nsnjournal.org/article.asp?issn=2636-865X;year=2020;volume=37;issue=4;spage=221;epage=227;aulast=Dilek

Reliability and validity of the Turkish version of the movement imagery questionnaire-3: Its cultural adaptation and psychometric properties

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10840098-604.01.01-E.399988

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.